Farmax India Limited reported audited standalone and consolidated cash flow results for the year ended March 31, 2016. For the period, on standalone basis, the company reported cash generated from operating activities of INR 4.128 million against INR 174.257 million a year ago. For the period, on consolidated basis, the company reported cash generated from operating activities of INR 4.128 million against INR 174.257 million a year ago.